Explore All Access
Check if your research matches the topics covered in TRANSLATIONAL LUNG CANCER RESEARCH?
- Degree of match
- Common matching concepts
- Additional journal recommendations
TRANSLATIONAL LUNG CANCER RESEARCH : Impact Factor & More
eISSN: 2226-4477pISSN: 2218-6751
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
TRANSLATIONAL LUNG CANCER RESEARCH Key Metrics
Topics Covered on TRANSLATIONAL LUNG CANCER RESEARCH
Cancer
Lung cancer
Computed tomography
Anaplastic lymphoma kinase
Progression-free survival
Mutant
Immunotherapy
Epidermal growth factor receptor
Lung
Immune checkpoint
Chemoradiotherapy
Overall survival
Artificial intelligence
Ablation
Lung squamous cell carcinoma
Toxicity
Confidence interval
Mesothelioma
Lung cancer screening
Surgical resection
TRANSLATIONAL LUNG CANCER RESEARCH Journal Specifications
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in TRANSLATIONAL LUNG CANCER RESEARCH ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in TRANSLATIONAL LUNG CANCER RESEARCH
Novel immunotherapy combinations in neoadjuvant non-small cell lung cancer (NSCLC): a better chance at cure?
- 1 Mar 2024
- Translational Lung Cancer Research
Development of a haematological indices-based nomogram for prognostic prediction and immunotherapy response assessment in primary pulmonary lymphoepithelioma-like carcinoma patients.
- 1 Mar 2024
- Translational lung cancer research
The use of intravenous indocyanine green in minimally invasive segmental lung resections: a systematic review.
- 1 Mar 2024
- Translational lung cancer research
Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cells.
- 1 Mar 2024
- Translational lung cancer research
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.
- 1 Mar 2024
- Translational lung cancer research
Revisiting the impact of clinicopathologic characteristics in PD-L1 profile in a large cohort of non-small cell lung cancer.
- 1 Mar 2024
- Translational lung cancer research
Novel immunotherapy combinations in neoadjuvant non-small cell lung cancer (NSCLC): a better chance at cure?
- 1 Mar 2024
- Translational Lung Cancer Research
Development of a haematological indices-based nomogram for prognostic prediction and immunotherapy response assessment in primary pulmonary lymphoepithelioma-like carcinoma patients.
- 1 Mar 2024
- Translational lung cancer research
The use of intravenous indocyanine green in minimally invasive segmental lung resections: a systematic review.
- 1 Mar 2024
- Translational lung cancer research
Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cells.
- 1 Mar 2024
- Translational lung cancer research
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.
- 1 Mar 2024
- Translational lung cancer research
Revisiting the impact of clinicopathologic characteristics in PD-L1 profile in a large cohort of non-small cell lung cancer.
- 1 Mar 2024
- Translational lung cancer research
Compare Similar Journals with TRANSLATIONAL LUNG CANCER RESEARCH
Select Journals to Compare with TRANSLATIONAL LUNG CANCER RESEARCH
Total journals - 10
You can select up to 3 Journals at a time
Journal of Thoracic Oncology
Publisher: ELSEVIER SCIENCE INC
Lung Cancer
Publisher: ELSEVIER IRELAND LTD
Annals of Oncology
Publisher: ELSEVIER
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Thoracic Cancer
Publisher: WILEY
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Clinical Lung Cancer
Publisher: CIG MEDIA GROUP, LP
Journal of Thoracic Disease
Publisher: AME PUBLISHING COMPANY
Cancers
Publisher: MDPI
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
TRANSLATIONAL LUNG CANCER RESEARCH
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on TRANSLATIONAL LUNG CANCER RESEARCH
How long has TRANSLATIONAL LUNG CANCER RESEARCH been actively publishing? 
TRANSLATIONAL LUNG CANCER RESEARCH has been in operation since 2012 till date.
What is the publishing frequency of TRANSLATIONAL LUNG CANCER RESEARCH?
TRANSLATIONAL LUNG CANCER RESEARCH published with a Bi-monthly frequency.
How many articles did TRANSLATIONAL LUNG CANCER RESEARCH publish last year?
In 2023, TRANSLATIONAL LUNG CANCER RESEARCH publsihed 247 articles.
What is the eISSN & pISSN for TRANSLATIONAL LUNG CANCER RESEARCH?
For TRANSLATIONAL LUNG CANCER RESEARCH, eISSN is 2226-4477 and pISSN is 2218-6751.
Who is the publisher of TRANSLATIONAL LUNG CANCER RESEARCH?
AME PUBLISHING COMPANY is the publisher of TRANSLATIONAL LUNG CANCER RESEARCH.
